Sunday, September 7, 2025

Common allergy spray slashes COVID-19 risk in surprising trial

A common hay fever nasal spray was found to cut COVID-19 infections by two-thirds in a clinical trial, while also reducing rhinovirus cases. Researchers believe it could serve as an easy, low-cost preventive measure, pending further studies.

from Top Health News -- ScienceDaily https://ift.tt/fDmxMdH

No comments:

Post a Comment

Stanford scientists regrow lost cartilage and reverse arthritis in major breakthrough

A new treatment that blocks an aging-related protein restored lost cartilage in old mice and helped prevent arthritis after knee injuries. H...